REGULATORY

• Relief Claims OK’ed for 5 More Deaths Possibly Linked to COVID Jabs
  June 20, 2023

• MHLW Study Group Proposes Flexibility in Launch Premium Criteria, Broader Comparators
  June 20, 2023

• MHLW Starts Clinical Study on Mpox Vaccine for People with High Infection Risks
  June 19, 2023

• PMDA to Establish Asia, US Hubs to Spur Innovative Drug Development
  June 19, 2023

• Japan OKs Honebuto Budget Policy Blueprint, Vows Debates on Longer-Term Drug Costs
  June 19, 2023

• Democratic Party For the People Calls for Drug Pricing Overhaul
  June 16, 2023

• First Generics for 11 APIs to Enter NHI Price List, Azilva Faces Most Contenders
  June 15, 2023

• MSD’s Lyfnua Braces for Price Cuts under CEA Scheme
  June 15, 2023

• Japan Diet Clears Lawmaker-Sponsored Dementia Bill
  June 15, 2023

• MHLW Mulls New OTC Class to Bar Online Sales amid Unease over Morning After Pills
  June 14, 2023

• LDP Policy Research Council Generally Approves Revised Honebuto Draft
  June 14, 2023

• Label Revision Ordered for Opdivo, Yervoy to Add Meningitis Risks
  June 14, 2023

• MHLW to Set Up Team Dedicated to Executing Healthcare DX Timeline
  June 13, 2023

• 3 Japan Manufacturers of Plasma-Derived Products Call for Changes in Export Rules: PAFSC Committee
  June 13, 2023

• Panelist Suggested Macroeconomic Indexing for Social Security Spending: CEFP Minutes
  June 13, 2023

• MHLW Publishes Final Report by Expert Panel on Comprehensive Pharma Policy
  June 13, 2023

• MHLW Panel OKs 170 More Health Damage Claims for COVID Vaccines
  June 13, 2023

• Japan Diet Enacts Genomic Medicine Promotion Bill
  June 12, 2023

• MHLW Calls for Switch from Noritren after Carcinogen Detection
  June 12, 2023

• Honebuto Social Security Debate Culminates with LDP Push for Nixing Budget Cap
  June 9, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 82
• 83
• 84
• 85
• 86
• 87
• 88
• 89
• 90
• …
• Next ›
• 最終 »